11 people suffering from bone loss in their jaws participated in a clinical trial to restore their jawbones. Fat tissue was extracted from each one. From the fat tissue, it seems that Bonus Biogroup, the biotech company can extract “t-cells” which are unique to each person and form the building blocks of many types of tissue.
In the lab, the extracted fat issue was used to grow a live, semi-liquid substance that was injected into the jaws of the patients. Over a few months the substance hardened and fused together with the jaw filling all the cracks and fissures into a complete, solid and healthy jaw.
Chief Executive Shai Meretzky was pleased to announce the first success in reconstructing damaged bone tissue with laboratory grown human bone grafting substances that were non-invasively injected and successfully transplanted.
Ora Burger a company VP, told Reuters that the transplants were successful in all 11 patients. They will proceed to clinical trials on long bones and extremities which pose a different set of challenges.
See video of original proposal which has now become a success!
